(Q51462051)

English

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

scientific article published on 18 May 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

0 references

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

12

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

object named as

Cecilia Linde

15

0 references

10

object named as

Axel Haverich

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

7

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

6

object named as

Michel Komajda

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

8

object named as

Otto A Smiseth

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

1

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

11

object named as

Arno Hoes

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Jerzy Korewicki

13

object named as

Jerzy Korewicki

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

author name string

Henry Dargie

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Helmut Drexler

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Ferenc Follath

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Antonello Gavazzi

9

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Samuel Lévy

14

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

José-Luis Lopez-Sendon

16

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Markku S Nieminen

17

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Luc Piérard

18

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Willem J Remme

19

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology

20

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

publication date

18 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

26

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

11

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

1115-1140

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The heart failure epidemic: exactly how big is it?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Trends in hospitalization for heart failure in Scotland 1980-1990.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Is the prognosis of heart failure improving?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Validity of clinical diagnosis of heart failure in primary health care

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Natural history of asymptomatic left ventricular systolic dysfunction in the community

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Factors determining symptoms in heart failure: comparison of fast and slow exercise tests

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) pro

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Analysis of the early transmitral Doppler velocity curve: effect of primary physiologic changes and compensatory preload adjustment

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Objective assessment of the response to treatment of severe heart failure using a 9-minute walk test on a patient-powered treadmill

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Systematic review of the management of atrial fibrillation in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Expert consensus document on beta-adrenergic receptor blockers

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The Economics of ICDs.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Long-term use of a left ventricular assist device for end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Hemofiltration as short-term treatment for refractory congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Task Force on Sudden Cardiac Death of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Heart failure disease management: a critical review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of education and support on self-care and resource utilization in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Predictors of late development of heart failure in stable survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

A standardized definition of ischemic cardiomyopathy for use in clinical research

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Determination of candidacy for mechanical circulatory support: importance of clinical indices

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

It cannot be cardiac failure because the heart is not enlarged on the chest X-ray

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI204

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHI204

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/15901669

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51462051&oldid=1570439808"